Medical Adhesive Repeat Application Study

Exclusion Criteria

• •1. If female, is pregnant, nursing, or planning a pregnancy during the study as determined by interview.
• •2. If female, is currently experiencing hot flashes (this affects the measurements) or has increased localized or generalized sweating (hyperhidrosis).
• •3. Is a smoker.
• •4. Has a history of lightening or darkening of the skin due to tape application and removal.
• •5. Has diabetes Type 1 or Type 2.
• •6. Has a current skin condition on the volar forearms (e.g., psoriasis, eczema, atopic dermatitis, etc., or active cancer) that the Investigator or designee deems inappropriate for participation or could interfere with the outcome of the study.
• •7. Is currently taking, or in the past 2 weeks has taken any anti-inflammatory drug (e.g., aspirin, ibuprofen, Celebrex \[COX-2 inhibitor\], corticosteroids), immunosuppressive drugs, or antihistamine medications.
• •8. Is currently applying, or in the past 2 weeks has applied topical drugs to the volar forearm test sites.
• •9. Has any medical condition that, in the Investigator's judgment, makes the Subject ineligible or places the Subject at undue risk.
• •10. Is currently participating in any clinical testing, including other studies being conducted at Dermico LLC.
• •11. Has damaged skin in or around the test sites, which includes sunburn, extremely deep tans, uneven skin tones, tattoos, scars, excessive hair that they are not willing to have clipped, numerous freckles, blemishes, or other disfiguration of the test sites.
• •12. Has a confirmed allergy or sensitivity to adhesives.
• •13. Has a history of a confirmed or suspected COVID-19 infection within 30 days prior to the study visit.
• •14. Has had contact with a COVID-19-infected person or persons within 14 days prior to the study visit.
• •15. Individual or a member of the individual's household has traveled internationally within 14 days prior to the study visit.
• •16. Has experienced any of the following self-reported symptoms of COVID-19 within 2 weeks prior to the study visit:
• •* Unexplained cough, shortness of breath/difficulty breathing, fatigue, body aches (headaches, muscle pain, stomachaches), conjunctivitis, loss of smell, loss of taste, poor appetite, nausea, vomiting, diarrhea, palpitations, or chest pain/tightness.
• •* Temperature ≥ 100. 4o F, measured